Pelthos Therapeutics Inc. (PTHS)
NYSE: PTHS · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2022
Filings
179 filings since 2017 beside 81 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Aug 18, 2026.
Filings a yearinsider forms included
5221016765
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Oct 30, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Aug 13, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest May 21, 2026.SEC letters: 13 in the last 36 months, the newest Feb 9, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 30, 2026
8-K items 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 5.07, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Change to shareholders' rights; Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote; Investor disclosure (Regulation FD) · Current report
Oct 1, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Sep 29, 2026
Aug 13, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 13, 2026
8-K item 4.02
Warning not to rely on past financial statements · Current report
Aug 12, 2026
May 21, 2026
8-K items 4.01, 5.02, 9.01
Auditor change; Officer or director change · Current report
May 15, 2026
May 14, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 10, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Mar 19, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Jan 13, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jan 12, 2026
Jan 12, 2026
8-K items 5.02, 7.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jan 6, 2026
Jan 2, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Dec 23, 2025
40 of 179 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.